Climb Bio (CLYM) Other Non-Current Liabilities (2020 - 2023)

Climb Bio (CLYM) has 3 years of Other Non-Current Liabilities data on file, last reported at $22000.0 in Q4 2023.

• Quarterly Other Non-Current Liabilities changed N/A year-over-year to $22000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $22000.0 (changed N/A YoY) and the FY2023 annual result came in at $22000.0, changed N/A from the prior year.
• Other Non-Current Liabilities declined to $22000.0 in Q4 2023, from $34000.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $551000.0 in Q4 2020 to a low of $7000.0 in Q4 2021.
• A 3-year average of $126000.0 and a median of $44500.0 in 2023 frame the typical range for Other Non-Current Liabilities.
• The widest YoY moves for Other Non-Current Liabilities: up 98.73% in 2021, down 98.73% in 2021.
• Tracing CLYM's Other Non-Current Liabilities over 3 years: stood at $551000.0 in 2020, then tumbled by 98.73% to $7000.0 in 2021, then soared by 214.29% to $22000.0 in 2023.
• The last three Other Non-Current Liabilities figures came in at $22000.0 (Q4 2023), $34000.0 (Q3 2023), and $55000.0 (Q2 2023), per Business Quant data.